146 related articles for article (PubMed ID: 19608395)
21. Sputum cytological atypia as a predictor of incident lung cancer in a cohort of heavy smokers with airflow obstruction.
Prindiville SA; Byers T; Hirsch FR; Franklin WA; Miller YE; Vu KO; Wolf HJ; Barón AE; Shroyer KR; Zeng C; Kennedy TC; Bunn PA
Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):987-93. PubMed ID: 14578133
[TBL] [Abstract][Full Text] [Related]
22. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
Xin XF; Zhao M; Li ZL; Song Y; Shi Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
[TBL] [Abstract][Full Text] [Related]
23. Lipid metabolite levels of prostaglandin D2 and eicosapentaenoic acid recovered from bronchoalveolar lavage fluid correlate with lung function of chronic obstructive pulmonary disease patients and controls.
Csanky E; Rühl R; Scholtz B; Vasko A; Takacs L; Hempel WM
Electrophoresis; 2009 Apr; 30(7):1228-34. PubMed ID: 19294692
[TBL] [Abstract][Full Text] [Related]
24. Proteomics of human lung tissue identifies surfactant protein A as a marker of chronic obstructive pulmonary disease.
Ohlmeier S; Vuolanto M; Toljamo T; Vuopala K; Salmenkivi K; Myllärniemi M; Kinnula VL
J Proteome Res; 2008 Dec; 7(12):5125-32. PubMed ID: 19367700
[TBL] [Abstract][Full Text] [Related]
25. Inflammatory and oxidative stress biomarkers in allergic rhinitis: the effect of smoking.
Tanou K; Koutsokera A; Kiropoulos TS; Maniati M; Papaioannou AI; Georga K; Zarogiannis S; Gourgoulianis KI; Kostikas K
Clin Exp Allergy; 2009 Mar; 39(3):345-53. PubMed ID: 19187324
[TBL] [Abstract][Full Text] [Related]
26. Correlation between serum biomarkers and BODE index in patients with stable COPD.
Liu SF; Chin CH; Wang CC; Lin MC
Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
[TBL] [Abstract][Full Text] [Related]
27. Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program.
Ferguson GT; Enright PL; Buist AS; Higgins MW
Respir Care; 2000 May; 45(5):513-30. PubMed ID: 10813228
[TBL] [Abstract][Full Text] [Related]
28. The clinical utility of biomarkers in asthma and COPD.
Snell N; Newbold P
Curr Opin Pharmacol; 2008 Jun; 8(3):222-35. PubMed ID: 18468485
[TBL] [Abstract][Full Text] [Related]
29. Markers of anti-oxidant response in tobacco smoke exposed subjects: a data-mining review.
Comandini A; Marzano V; Curradi G; Federici G; Urbani A; Saltini C
Pulm Pharmacol Ther; 2010 Dec; 23(6):482-92. PubMed ID: 20594977
[TBL] [Abstract][Full Text] [Related]
30. Non-invasive biomarkers of lung inflammation in smoking subjects.
Malerba M; Montuschi P
Curr Med Chem; 2012; 19(2):187-96. PubMed ID: 22320297
[TBL] [Abstract][Full Text] [Related]
31. Chronic obstructive pulmonary disease. Inflammation of small airways and lung parenchyma.
Cosio MG; Guerassimov A
Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 2):S21-5. PubMed ID: 10556164
[TBL] [Abstract][Full Text] [Related]
32. Acute effects of cigarette smoking on inflammation in healthy intermittent smokers.
van der Vaart H; Postma DS; Timens W; Hylkema MN; Willemse BW; Boezen HM; Vonk JM; de Reus DM; Kauffman HF; ten Hacken NH
Respir Res; 2005 Mar; 6(1):22. PubMed ID: 15740629
[TBL] [Abstract][Full Text] [Related]
33. Determinants of susceptibility to cigarette smoke. Potential roles for neuroendocrine cells and neuropeptides in airway inflammation, airway wall remodeling, and chronic airflow obstruction.
Aguayo SM
Am J Respir Crit Care Med; 1994 Jun; 149(6):1692-8. PubMed ID: 7911710
[TBL] [Abstract][Full Text] [Related]
34. Integrin upregulation on sputum neutrophils in smokers with chronic airway obstruction.
Maestrelli P; Calcagni PG; Saetta M; Bertin T; Mapp CE; Sanna A; Veriter C; Fabbri LM; Stanescu D
Am J Respir Crit Care Med; 1996 Nov; 154(5):1296-300. PubMed ID: 8912739
[TBL] [Abstract][Full Text] [Related]
35. Proteomics in detection and monitoring of asthma and smoking-related lung diseases.
Lin JL; Bonnichsen MH; Nogeh EU; Raftery MJ; Thomas PS
Expert Rev Proteomics; 2010 Jun; 7(3):361-72. PubMed ID: 20536308
[TBL] [Abstract][Full Text] [Related]
36. Analysis of sputum in COPD.
Maestrelli P; Richeldi L; Moretti M; Fabbri LM
Thorax; 2001 Jun; 56(6):420-2. PubMed ID: 11359954
[No Abstract] [Full Text] [Related]
37. Reproducibility of biomarkers in induced sputum and in serum from chronic smokers.
Zuiker RG; Kamerling IM; Morelli N; Calderon C; Boot JD; de Kam M; Diamant Z; Burggraaf J; Cohen AF
Pulm Pharmacol Ther; 2015 Aug; 33():81-6. PubMed ID: 25966831
[TBL] [Abstract][Full Text] [Related]
38. Serum lysozyme - a surrogate marker of pulmonary microvascular injury in smokers?
Schmekel B; Blomstrand P; Venge P
Clin Physiol Funct Imaging; 2013 Jul; 33(4):307-12. PubMed ID: 23692621
[TBL] [Abstract][Full Text] [Related]
39. Occupational exposures: evidence for a causal association with chronic obstructive pulmonary disease.
Becklake MR
Am Rev Respir Dis; 1989 Sep; 140(3 Pt 2):S85-91. PubMed ID: 2675712
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of bronchial obstruction in a tobacco smoke exposed population - the PNEUMOBIL project.
Reis Ferreira JM; Matos MJ; Rodrigues F; Belo A; Brites H; Cardoso J; Simão P; Dos Santos JM; Almeida J; Gouveia A; Bárbara C
Rev Port Pneumol; 2009; 15(5):803-46. PubMed ID: 19649542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
